Exploring RNA-based therapeutics for Crohn’s disease: Aman Saifi presents GENEGUT research at Ghent Gut Inflammation Meeting
On 15 May 2025, GENEGUT PhD student Aman Saifi (University College Cork, Ireland) presented a poster at the 5th Ghent Gut Inflammation Group Meeting, a leading European event focused on gut immunology and inflammation.
GENEGUT partner CarboHyde hosts internal seminar on cyclodextrin research at UCC, Cork
CarboHyde recently organised an internal seminar titled “Revolution of Cyclodextrins.” The seminar was held at University College Cork (UCC) in Ireland, bringing together project researchers to explore recent advances in cyclodextrin science relevant to GENEGUT’s mission.
GENEGUT Behind the Scenes: Capsugel France SAS | Lonza Capsules and Health Ingredients
Welcome to another edition of our “GENEGUT: Behind the Scenes” series — where we spotlight the passionate teams driving innovation across the GENEGUT project. Today, we introduce Capsugel France SAS | Lonza Capsules and Health Ingredients, based in France.
HNN 3.0 Success Story: Caitriona O’Driscoll on leading GENEGUT towards an oral RNA-based therapy for Crohn’s Disease
Prof. Caitriona O’Driscoll, coordinator of the GENEGUT project, was recently interviewed by HNN 3.0 as part of their Horizon Health Impact Success Stories series.
GENEGUT’s 7th General Assembly in Uppsala: From scientific milestones to future pathways
On 25–26 June 2025, the GENEGUT consortium convened for its 7th General Assembly meeting, hosted by Uppsala University (UU) in Sweden. The two-day meeting marked project month 33 and brought together over 30 participants representing all nine project partners.
GENEGUT Behind the Scenes: CarboHyde
Welcome to the next edition of our “GENEGUT: Behind the Scenes” series — where we spotlight the passionate teams driving innovation across the GENEGUT project. Today, we introduce CarboHyde, based in Budapest, Hungary.